Treatment of APAP Toxicity With IV and Oral NAC 2008-2011
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01465542|
Recruitment Status : Completed
First Posted : November 4, 2011
Last Update Posted : September 11, 2017
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||47 participants|
|Official Title:||Treatment of Acetaminophen Toxicity With Intravenous vs. Oral N-acetylcysteine: A Retrospective Review|
|Study Start Date :||June 2011|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||November 2011|
Patients receiving oral NAC treatment after an acute acetaminophen ingestion.
Patients receiving IV NAC after an acute Acetaminophen ingestion.
- Length of NAC treatment in hours [ Time Frame: Retrospective data collection for patient's hospital admission, max estimated 5days ]Length of NAC treatment (in hours) for both IV and PO formulations used in patients with APAP toxicity
- Pharmacology & Toxicology consults [ Time Frame: Retrospective data collection for length of patient's hospital admission, max estimated 5 days ]Documenting whether or not a pharmacology & toxicology consult was obtained during the patient's hospital admission for APAP toxicity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01465542
|United States, Ohio|
|Children's Hospital Medical Center of Akron|
|Akron, Ohio, United States, 44308|
|Principal Investigator:||Martha Blackford, PharmD||CHMCA|